Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3916519, 9 pages
Research Article

Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens

1Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, 5262100 Ramat-Gan, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, 6997801 Tel-Aviv, Israel
3Department of Internal Medicine B, Sheba Medical Center, 5262100 Tel Hashomer, Israel
4Unité Différenciation Epithéliale et Autoimmunité Rhumatoïde, Université de Toulouse-INSERM, Toulouse, France
5Laboratoire de Biologie Cellulaire et Cytologie, CHU de Toulouse, Toulouse, France
6Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, 6997801 Tel Aviv, Israel

Correspondence should be addressed to Smadar Gertel; li.vog.htlaeh.abehs@letreg.radams

Received 23 January 2017; Revised 19 April 2017; Accepted 11 May 2017; Published 21 June 2017

Academic Editor: Tânia Silvia Fröde

Copyright © 2017 Smadar Gertel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Smadar Gertel, Gidi Karmon, Sivan Vainer, et al., “Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens,” Mediators of Inflammation, vol. 2017, Article ID 3916519, 9 pages, 2017.